You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SYNTAX Score II

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Diseases, Cardiovascular Diseases, 3 Vessel Coronary Artery Disease Trial in Worldwide (Coronary stent, Multi Slice

Completed
Has Results
  • Heart Diseases
  • +2 more
  • Coronary stent
  • +4 more
  • Amsterdam, Noord Holland, Netherlands
  • +21 more
Jul 12, 2022

Residual Syntax Score to Predict Outcome After Acute Myocardial

Recruiting
  • Myocardial Infarction
  • Residual syntax score
  • Cairo, Egypt
    Cairo University hospitals
May 30, 2022

Residual Syntax Score and Syntax Revascularization Index on

Completed
  • STEMI - ST Elevation Myocardial Infarction
  • +3 more
  • Residual SYNTAX Score
  • SYNTAX Revascularization Index
  • Assiut, Egypt
    Assiut University Heart Hospital
Feb 15, 2022

In-hospital and Short-term Clinical Outcomes in STEMI Patients

Not yet recruiting
  • STEMI
    • Assiut, Egypt
      Abdelrahman Ragab
    Nov 3, 2023

    Before Coronary Artery Bypass Surgery

    Not yet recruiting
    • Coronary Artery Disease
    • Abdominal Aortic Aneurysm
    • Abdominal aortic Duplex ultrasound
    • (no location specified)
    Jul 6, 2022

    The New ICU Prognostic Score APACHE-INf

    Recruiting
    • Intensive Care Unit
    • +2 more
    • Prognosis Scoring
    • Nilüfer, Bursa, Turkey
      University of Health Sciences, Bursa Sehir Training & Research H
    Jul 13, 2023

    The Naples Pediatric Food Allergy (NAPFA) Score

    Recruiting
    • Food Allergy in Children
    • Development of the NAPFA score
    • Naples, Italy
      Department of Traslational Medical Science - University of Naple
    Jan 23, 2023

    HF - Heart Failure Trial in Italy (CPET and related variables evaluation)

    Recruiting
    • HF - Heart Failure
    • CPET and related variables evaluation
    • Milano, Milan, Italy
    • +3 more
    Oct 2, 2023

    Gestational Trophoblastic Neoplasia Trial in Beijing (Toripalimab, Actinomycin-D)

    Not yet recruiting
    • Gestational Trophoblastic Neoplasia
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 1, 2023

    Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based

    Not yet recruiting
    • Breast Cancer
    • Cancer of the Breast
    • VENTANA MIB-1 Ki67 assay
    • +4 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Apr 18, 2023

    Hepatocellular Carcinoma by BCLC Stage Trial in Rennes (Tislelizumab)

    Not yet recruiting
    • Hepatocellular Carcinoma by BCLC Stage
    • Rennes, France
      Centre Eugene Marquis
    Jan 16, 2023

    Heme Oxygenase 1 Enzyme Level and Coronary SYNTAX Score

    Completed
    • Coronary Artery Disease
    • Oxidative Stress
      • Istanbul, Turkey
        Yeditepe University Hospital
      Jun 19, 2020

      Neuroendocrine Tumours (NET), Neuroendocrine Carcinomas (NEC) Trial in Spain (177Lu-Dotatate, Nivolumab)

      Recruiting
      • Neuroendocrine Tumours (NET)
      • Neuroendocrine Carcinomas (NEC)
      • Santiago De Compostela, Galicia, Spain
      • +4 more
      Aug 1, 2022

      Locally Advanced Rectal Cancer Trial in Guangzhou (Fruquintinib plus Tislelizumab)

      Not yet recruiting
      • Locally Advanced Rectal Cancer
      • Fruquintinib plus Tislelizumab
      • Guangzhou, Guangdong, China
        651 Dongfeng Road East
      Aug 3, 2021

      Pituitary Adenoma Trial in Worldwide

      Completed
      • Pituitary Adenoma
        • New York, New York
        • +9 more
        Dec 2, 2021

        Modified Pediatric Early Warning Score and Modified PRISA II

        Recruiting
        • Critical Illness
        • no intervention
        • Trabzon, Turkey
          Karadeniz Technical University Faculty of Medicine Farabi Hospit
        May 8, 2021

        Breast Cancer Trial in New Haven (Everolimus)

        Terminated
        Has Results
        • Breast Cancer
        • New Haven, Connecticut
          Yale University
        Jan 12, 2022

        Familial Hypercholesterolemia - Heterozygous Trial in Paris (CAC Score)

        Completed
        • Familial Hypercholesterolemia - Heterozygous
        • CAC Score
        • Paris, France
          Hôpital Pitié-Salpêtrière
        Sep 9, 2021

        Esophageal Cancer, Chemoradiotherapy, Nimotuzumab Trial in Beijing (Radiotherapy, Nimotuzumab, S-1)

        Recruiting
        • Esophageal Cancer
        • +3 more
        • Radiotherapy
        • +2 more
        • Beijing, China
          Department of Radiation Oncology, National Cancer Center/Nationa
        Oct 21, 2021

        Bypass Complication, Cardioplegia Solution Adverse Reaction, Endothelial Degeneration Trial in Istanbul (Endocan, E-Selectin,

        Active, not recruiting
        • Bypass Complication
        • +5 more
        • Endocan, E-Selectin, TNF-alpha, Total Oxidant and Antioxidant Status
        • Istanbul, Turkey
          Dr. Siyami Ersek Hospital
        Oct 28, 2022

        Coronary Artery Bypass Grafting, Mortality Trial in Istanbul (Cardiac surgery score and APACHE II scoring)

        Completed
        • Coronary Artery Bypass Grafting
        • Mortality
        • Cardiac surgery score and APACHE II scoring
        • Istanbul, Turkey
        • +1 more
        Aug 23, 2021

        Coronary Artery Disease, Atherosclerosis, Coronary, Hiv Trial in Moscow (Quantitative coronary angiography, intravascular

        Enrolling by invitation
        • Coronary Artery Disease
        • +4 more
        • Quantitative coronary angiography, intravascular imaging with percutaneous intervention
        • Moscow, Russian Federation
        • +1 more
        Mar 12, 2022

        Score With PET/CT for Anal Squamous Cell Cancer

        Recruiting
        • Anal Squamous Cell Carcinoma
        • +9 more
        • Computed Tomography
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 7, 2022

        Lung Cancer, Non Small Cell Lung Cancer, NSCLC Stage I Trial in Canada (Selective Targeted Sampling, Systematic Sampling)

        Completed
        • Lung Cancer
        • +3 more
        • Selective Targeted Sampling
        • Systematic Sampling
        • Edmonton, Alberta, Canada
        • +6 more
        Jul 25, 2022

        Acute Myeloid Leukemia Trial in Spain (Quizartinib, Fludarabine, Cytarabine)

        Active, not recruiting
        • Acute Myeloid Leukemia
        • Alicante, Spain
        • +19 more
        Mar 11, 2022